Supported the journey from MVP to Series A
AI pharmacovigilance SaaS
Biologit
From algorithmic MVP to a secure SaaS platform for pharmaceutical safety intelligence.
01 · The challenge
The business problem.
Biologit had an AI algorithm for identifying pharmacovigilance signals in medical literature and needed a usable, secure product around it.
02 · The solution
What Seditio built.
Seditio designed the platform and UI/UX, integrated the algorithm API, scaled the architecture and built and managed a distributed development team working with the Ireland-based company.
03 · Documented impact01 02 03 04
What changed.
Platform designed to process more than 120 million medical abstracts
Microservices architecture documented as handling more than 1 million daily API calls
Development team coordinated across three time zones
Technology and capability
The working system.
Technology choices reflect the needs documented in Seditio's portfolio and founder CV.
AI/MLAPI integrationMicroservicesGoogle CloudUI/UXISO 27001-aligned controls
Build what comes next
Book a consultationHave a similarly complex product or platform?
Share the workflow, systems and outcome you need. We will help make the delivery path concrete.